Zusammenfassung
5-Bromo-1-propyl-, 1-Benzyl-, 1-Phenyl- und 1-Butyl-2-(α-oxy-benzyl-benzimidazol hemmen die cytopathische Wirkung (HeLa Zelle) von Vaccinia-Virus.
Reference
D. G. O'Sullivan, D. Pantic, D. S. Dane andM. Briggs, Lancet1, 446 (1969).
H. J. Eggers andI. Tamm, J. exp. Med.113, 657 (1961).
L. J. Reed andH. Muench, Am. J. Hyg.27, 493 (1938).
D. G. O'Sullivan andC. M. Ludlow, Arch. ges. Virusforsch.41, 295 (1973).
R. R. A. Coombs, M. R. Daniel, B. W. Gurner andA. Kelus, Natur, Lond.189, 503 (1961).
W. H. Prusoff, Pharmac. Rev.19, 216 (1967).
F. W. Sheffield, D. J. Bauer andS. M. Stephenson, Brit. J. exp. Path.41, 638 (1960).
D. G. O'Sullivan, P. W. Sadler andL. Rice, Proceedings of the Third International Congress of Chemotherapy (Georg Thieme, Stuttgart 1964), p. 879.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
O'Sullivan, D.G., Ludlow, C.M. & Doromal, V.C. Protection of vaccinia-infected HeLa cells by lipophilic benzimidazole derivatives. Experientia 30, 1122–1124 (1974). https://doi.org/10.1007/BF01923644
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01923644